FIELD: organic chemistry. SUBSTANCE: product: N-sulfonyltyrosine 4-(4-pyridyl)-butyl ester of the formula (I) C4H9SO2Cl or its pharmaceutically acceptable salts. Reagent 1: tyrosine. Reagent 2: n-Br(CH2)4Cl. Reagent 3: methylated pyridine. Reagent 4: . Product of interaction of reagents 1 and 2 is subjected for reaction with product of interaction of reagents 3 and 4. Reaction conditions: in the presence of alkali. Product of the formula (I) is subjected for selective hydrogenation using Pd/C in acetic acid and product of the formula (II) is obtained. Synthesized compound is used in medicine as an antagonist of fibrinogen receptors. EFFECT: improved method of synthesis. 4 cl, 1 ex
Title |
Year |
Author |
Number |
METHOD OF SYNTHESIS OF TYROSINE DERIVATIVES |
1994 |
- Dzhon I.A.Chang[Us]
- Dehvid L.Kh'Judzhes[Us]
- Dehlian Zao[Cn]
|
RU2097377C1 |
METHOD FOR PRODUCTION OF TYROSINE DERIVATIVES |
1993 |
- Dzhon I.L.Chang
- Dehvid L.Kh'Judzhes
- Dehlian Zao
|
RU2113432C1 |
SUBSTITUTED HETEROCYCLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION FOR BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS, METHOD OF BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS |
1993 |
- Konrad P.Dorn
- Dzheffri Dzh.Khejl
- Mal'Kol'M Mehkkoss
- Sander Dzh.Millz
- Tamara Lehdduvakhetti
- Shrenik K.Shakh
|
RU2140914C1 |
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS |
1995 |
- Konrad P. Dorn
- Dzheffri Dzh. Khejl
- Mal'Kol'M Makkoss
- Sander G. Mills
|
RU2170233C2 |
CYCLIC PEPTIDES OR THEIR ADDITIVE ACID SALTS, A COMPOSITION SHOWING ANTIFUNGAL AND ANTIPNEUMOCYSTOSIS ACTIVITY, A METHOD OF TREATMENT OF PATIENTS WITH FUNGAL INFECTIONS |
1994 |
- Dzhejms M.Balkovek
- Frehnsis Ehjlin Buffard
- Regina M.Blehk
|
RU2122548C1 |
IMIDAZOLIDYLIC MACROLIDE OR ITS ISOMERS, OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING IMMUNOSUPPRESSIVE ACTIVITY |
1992 |
- Mark Goulet[Us]
- Piter Dzh.Sinklejr[Us]
- Frederik Vong[Us]
- Mehtt'Ju Dzh.Vivratt[Us]
|
RU2108338C1 |
COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION |
1992 |
- Uil'Jam Dzh.Krist[Us]
- Linn D.Khoukins[Us]
- Osamu Asano[Jp]
- Tsutomu Kavata[Jp]
- Sejiti Kobajasi[Jp]
- Daniehl' P.Rossin'Ol'[Us]
|
RU2095366C1 |
INHIBITORS OF HIV-PROTEASE |
1994 |
- Dzhoel R.Khaff
- Dzhozef P.Vakka
- Brjus D.Dorsi
|
RU2137768C1 |
METHOD OF PREPARING 7,7-DIOXIDE 5,6-DIHYDRO (S) -4- (ALKILAMINO)-(S)-6- ALKYL-4H- THIENO (2,3-b) THIOPYRAN - 2-SULFONAMIDE AND 7,7-DIOXIDE 5,6-DIHYDRO(S)-4- (ACYLAMIDO)-(S)-6-ALKYL-4H-THIENO (2,3-b)THIOPYRAN |
1994 |
- Pol Sokhar
- Dehvid Dzh.Matr
- Tomas Dzh.Blehklok
|
RU2114851C1 |
METHOD OF PREPARING 5-(1,2,4-TRIAZOL-1-YL)TRIPTAMINE COMPOUNDS, AND 2-[5- (1,2,4-TRIAZOL-1-YL)-1H-INDOL-3-YL]ETHANOL |
1995 |
- Cheng J.Chen
- Robert D.Larsen
- Tomas R.Verkhoehven
|
RU2138496C1 |